Showing results (111-120 of 133) with videos related to

Sort By:
Pageof 14
Annals of Hematology|March 20, 2016
Splenic irradiation before hematopoietic stem cell transplantation for chronic myeloid leukemia: long-term follow-up of a prospective randomized studyAlois Gratwohl, Simona Iacobelli, Natalia Bootsman, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 19, 2020
Matched-Pair Analysis of Transplant from Haploidentical, Unmanipulated Bone Marrow Donor versus HLA Identical Sibling for Patients with Hematologic MalignanciesWilliam Arcese, Raffaella Cerretti, Loredana Sarmati, et al.
Haematologica|February 9, 2018
Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMTNico Gagelmann, Diderik-Jan Eikema, Simona Iacobelli, et al.
International Journal of Molecular Sciences|March 22, 2019
Association between CMV and Invasive Fungal Infections After Autologous Stem Cell Transplant in Lymphoproliferative Malignancies: Opportunistic Partnership or Cause-Effect Relationship?Francesco Marchesi, Fulvia Pimpinelli, Enea Gino Di Domenico, et al.
BMC Cancer|November 25, 2020
Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patientsLuca Castagna, Alessandro Busca, Stefania Bramanti, et al.
Haematologica|June 29, 2014
Engraftment kinetics and graft failure after single umbilical cord blood transplantation using a myeloablative conditioning regimenAnnalisa Ruggeri, Myriam Labopin, Maria Pia Sormani, et al.
Blood|October 22, 2013
Impact of allele-level HLA matching on outcomes after myeloablative single unit umbilical cord blood transplantation for hematologic malignancyMary Eapen, John P Klein, Annalisa Ruggeri, et al.
Blood Advances|November 3, 2021
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocolFrancesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, et al.
Blood Cancer Journal|August 27, 2020
Characterization of FLT3-ITDmut acute myeloid leukemia: molecular profiling of leukemic precursor cellsSerena Travaglini, Daniela Francesca Angelini, Valentina Alfonso, et al.
British Journal of Haematology|August 16, 2002
A single high dose of idarubicin combined with high-dose ARA-C for treatment of first relapse in childhood 'high-risk' acute lymphoblastic leukaemia: a study of the AIEOP groupAnna Maria Testi, Ilaria Del Giudice, William Arcese, et al.
Pageof 14